Infigratinib phosphate,
1310746-10-1,
NVP-BGJ398 phosphate,
UNII-58BH47BV6S,
58BH47BV6S,
CHEMBL1834657,
Urea, N'-(2,6-dichloro-3,5-dimethoxyphenyl)-N-(6-((4-(4-ethyl-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)-N-methyl-, phosphate (1:1),
BGJ-398 phosphate,
Infigratinib monophosphate,
Urea, N'-(2,6-dichloro-3,5-dimethoxyphenyl)-N-[6-[[4-(4-ethyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]-N-methyl-, phosphate (1:1),
BGJ 398 phosphate,
NVP BGJ398 phosphate,
NVP-BGJ398-phosphate,
NVP-BGJ398 (phosphate),
SCHEMBL14893408,
BCP18561,
EX-A1550,
HY-13311A,
AKOS030526400,
BGJ-398,NVP-BGJ398,Infigratinib,
CS-1559,
3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-methylurea phosphate,
3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)phenylamino)pyrimidin-4-yl)-1-methylurea phosphate,
A15194,
3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl- piperazin-1-yl)-phenylamino]-pyrimid-4-yl}-1-methyl-urea monophosphate,
872511-34-7,